Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. The company is headquartered in Basel, Basel-Stadt and currently employs 75,883 full-time employees. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Follow-Up Questions
What is the price performance of NVS stock?
The current price of NVS is $123.64, it has decreased 0.17% in the last trading day.
What are the primary business themes or industries for Novartis AG?
Novartis AG belongs to Pharmaceuticals industry and the sector is Health Care
What is Novartis AG market cap?
Novartis AG's current market cap is $239.3B
Is Novartis AG a buy, sell, or hold?
According to wall street analysts, 24 analysts have made analyst ratings for Novartis AG, including 5 strong buy, 8 buy, 15 hold, 3 sell, and 5 strong sell
